Evidence of Chronic Chlamydia pneumoniae Infection in Patients with Behc¸et's Disease

References

• Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, et al. Mucocutaneous criteria for the diagnosis of Behçet’s disease: an analysis of clinicopathological data from multiple international centres. J Am Acad Dermatol 1995; 32: 968–76.
   PubMedGoogle Scholar
• Ayaslioglu E, Erkek E, Kilic D, Kaygusuz S, Karaca F, Duzgun N. Tetanus antitoxin seroprevalence in patients with Behcet’s disease. Scand J Infect Dis 2003; 35: 299–301.
   PubMed Web of Science ®Google Scholar
• Sakane T, Suzuki N, Nagafuchi H. Aetiopathology of Behcet’s disease: immunological aspects. Yonsei Med J 1997; 38: 350–8.
   PubMedGoogle Scholar
• Önder M, Gurer MA. The multiple faces of Behcet’s disease and its aetiological factors. J Eur Acad Dermatol 2001; 15: 126–36.
   Google Scholar
• Gencay M, Jochen JR, Tamm M, Soler M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Resp Crit Care Med 2000; 163: 1097–2006.
   Google Scholar
• Hertzan L, Vasankari T, Liippo K, Wahlström E, Puolakkainen M. Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis 2002; 34: 22–7.
   Google Scholar
• Hahn D. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 1999; 83: 271–88.
   PubMed Web of Science ®Google Scholar
• Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983–6.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in atherosclerotic tissue. J Infect Dis 2000; 181\(Suppl 3): 437–40.
   Google Scholar
• Schumacher A, Seljeflot I, Lerkerod AB, Sommervoll L, Otterstad JE, Arnesen H. Does infection with Chlamydia pneumoniae and or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? Clin Microbiol Infect 2002; 8: 654–61.
   PubMedGoogle Scholar
• Ljungstrom L, Franzen C, Schlaug M, Elowson S, Viidas U. Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels. Scand J Infect Dis Suppl 1997; 104: 37–40.
   Google Scholar
• Cascina A, Marone Bianco A, Mangiarotti P, Montecucco CM, Meloni F. Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case. Clin Exp Rheumatol 2002; 20: 845–7.
   PubMedGoogle Scholar
• International Study Group for Behcet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet 1990; 335: 1078–80.
   PubMed Web of Science ®Google Scholar
• Koivisto AL, Isoaho R, Von Hertzen L, Toyryla M, Laippala P, Kivela SL, Saikku P. Chlamydial antibodies in an elderly Finnish population. Scand J Infect Dis 1999; 31: 135–9.
   Google Scholar
• Saikku P, Wang SP, Kleemola M, Brander E, Rusanen E, Grayston JT An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985; 151: 832–9.
   PubMed Web of Science ®Google Scholar
• Sundelof B, Gnarpe H, Gnarpe J. An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum. Scand J Infect Dis 1993; 25: 259–61.
   Google Scholar
• Gran JT, Hjetland R, Andreassen AH. Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993; 22: 43–4.
   Google Scholar
• Halme S, Juvonen T, Laurila A, Juvonen J, Mosorin M, Saikku P, Surcel HM. Chlamydia pneumoniae reactive T-lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest 1999; 29: 546–52.
   Google Scholar
• Wagner AD, Gerard HC, Fresemann T, Schmidt WA, Gromnica-Ihle E, Hudson AP, Zeidler H. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000; 43: 1543–51.
   Google Scholar
• Koster T, Rosendaal FR, Lieuw-A-Len DD, Kroes AC, Emmerich JD, van Dissel JT. Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis. Lancet 2000; 355: 1694–5.
   Google Scholar
• Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 1994; 16: 313–9.
   Google Scholar
• Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ, Gaston JS. Tlymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol 2000; 12: 261–9.
   Google Scholar
• Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. C. pneumoniae Workshop participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada), Clin Infect Dis 200; 33: 492–503.
   Google Scholar
• Schumacher A, Lerkerod AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE, Arnesen H. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 2000; 39: 1859–64.
   Google Scholar
• Tapia O, Slepenkin A, Sevrioukov E, Hamor K, de la Maza LM, Peterson EM. Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol 2002; 9: 562–7.
   Google Scholar
• Hermann C, Graf K, Groh A, Straube E, Hartung T. Comparison of 11 commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 2002; 40: 1603–9.
   Google Scholar